Mutations of the thyroglobulin gene and its relevance to thyroid disorders

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 16, Issue 5, 2009, Pages 373-378

  Rubio, Ileana G S ^a   Medeiros Neto, Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; Cancer; Congenital hypothyroidism8mutations; Thyroglobulin

Indexed keywords

CHAPERONE; IODINE; LEVOTHYROXINE; LIOTHYRONINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BRAIN DEVELOPMENT; CANCER RISK; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; COLLOID; CONGENITAL HYPOTHYROIDISM; DEVELOPMENTAL DISORDER; DIAGNOSTIC PROCEDURE; ENVIRONMENTAL FACTOR; EUTHYROIDISM; FOUNDER EFFECT; FRAMESHIFT MUTATION; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GOITER; HORMONE ACTION; HUMAN; HYPOPHYSIS THYROID SYSTEM; INTELLECT; INTRACELLULAR SPACE; IODINE DEFICIENCY; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; NUTRITION; PHENOTYPE; POINT MUTATION; POSTNATAL GROWTH; PRENATAL CARE; PRENATAL PERIOD; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; THYROID CANCER; THYROID CARCINOMA; THYROID DISEASE; THYROID HORMONE SYNTHESIS; THYROTROPIN BLOOD LEVEL;

DIMERIZATION; FETAL DISEASES; GENOTYPE; HUMANS; MUTATION; PHENOTYPE; PROTEIN TRANSPORT; THYROGLOBULIN; THYROID DISEASES; THYROID GLAND;

EID: 69349100576     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32832ff218     Document Type: Review

References (63)

1. Rivolta CM, Targovnik HM. Molecular advances in thyroglobulin disorders. Clin Chim Acta 2006; 374:8-24.
2. Loeber JG. Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis 2007; 30:430-438.
3. Knobel M, Medeiros-Neto G. An outline of inherited disorders of the thyroid hormone generating system. Thyroid 2003; 13:771-801. (Pubitemid 37070158)
4. Vono-Toniolo J, Rivolta CM, Targovnik HM, et al. Naturally occurring mutations in the thyroglobulin gene. Thyroid 2005; 15:1021-1033. (Pubitemid 41475712)
5. Bizhanova A, Kopp P. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 2009; 150:1084-1090. This complete review explains the mechanisms of the iodine traffic inside the cell.
6. Moreno JC, Visser TJ. New phenotypes in thyroid dyshormonogenesis: hypothyroidism due to DUOX2 mutations. Endocr Dev 2007; 10:99-117.
7. Zamproni I, Grasberger H, Cortinovis F, et al. Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 2008; 93:605-610. This is the first report that described mutations in the DUOXA2 gene associated to congenital hypothyroidism. This gene and its paralog DUOXA1 have been recently described as maturation factors for dual oxidase. (Pubitemid 351240837)
8. Moreno JC, Klootwijk W, van Toor H, et al. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med 2008; 358:1811-1818. This study described for the first time mutations in the deiodinase gene DEHAL1 in patients with congenital hypothyroidism. Functional studies have shown the reduction in activity of the mutant proteins. (Pubitemid 351581193)
9. Fukata S, Hishinuma A, Kuma K, et al. Endemic goiter due to thyroglobulin gene abnormality and social ostracism. Endocr J 2007; 54:485-486.
10. Hishinuma A, Fukata S, Ieiri T. Emerging new features of patients with thyroglobulin mutations, including increased incidence of thyroid cancer. Hot Thyroidology 2007; 3.
11. Rose SR. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006; 117:2290-2303. (Pubitemid 46071281)
12. Targovnik HM, Vono J, Billerbeck AE, et al. A 138-nucleotide deletion in the thyroglobulin ribonucleic acid messenger in a congenital goiter with defective thyroglobulin synthesis. J Clin Endocrinol Metab 1995; 80:3356-3360.
13. Fugazzola L, Persani L, Vannucchi G, et al. Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy. Eur J Nucl Med Mol Imaging 2007; 34:1498-1503. (Pubitemid 47312584)
14. Pardo V, Rubio IGS, Knobel M, et al. Phenotypic variation among four family members with congenital hypothyroidism caused by two distinct thyroglobulin gene mutations. Thyroid 2008; 18:783-786. (Pubitemid 352009923)
15. Targovnik HM, Frechtel GD, Varela V, et al. Human thyroid tissue do not express thyroalbumin. J Endocrinol Invest 1993; 16:415-419. (Pubitemid 23288396)
16. Caputo M, Rivolta CM, Gutnisky VJ, et al. Recurrence of the p.R277X/p.R1511X compound heterozygous mutation in the thyroglobulin gene in unrelated families with congenital goiter and hypothyroidism: haplotype analysis using intragenic thyroglobulin polymorphisms. J Endocrinol 2007; 195:167-177. (Pubitemid 350056010)
17. Ghazi A-AM, Ordookhani A, Pourafkari M, et al. Intrauterine diagnosis and management of fetal goitrous hypothyroidism: a report of an Iranian family with three consecutive pregnancies complicated by fetal goiter. Thyroid 2005; 15:1341-1347. (Pubitemid 43132680)
18. Medeiros-Neto G, Bunduki V, Tomimori E, et al. Prenatal diagnosis and treatment of dyshormonogenetic fetal goiter due to defective thyroglobulin synthesis. J Clin Endocrinol Metab 1997; 82:4239-4242.
19. Caputo M, Rivolta CM, Esperante SA, et al. Congenital hypothyroidism with goitre caused by new mutations in the thyroglobulin gene. Clin Endocrinol 2007; 67:351-357. (Pubitemid 47283829)
20. Rubio IG, Galrao AL, Pardo V, et al. A molecular analysis and long-term followup of two siblings with severe congenital hypothyroidism carrying the IVS30+1G>T intronic thyroglobulin mutation. Arq Bras Endocrinol Metabol 2008; 52:1337-1344. This study shows the clinical evaluation during a long-term follow-up of a patient who received LT4 intra-uterus treatment. The fetal treatment is described in Ref. [18].
21. Kanou Y, Hishinuma A, Tsunekawa K, et al. Thyroglobulin gene mutations producing defective intracellular transport of thyroglobulin are associated with increased thyroidal type 2 iodothyronine deiodinase activity. J Clin Endocrinol Metab 2007; 92:1451-1457. (Pubitemid 46556425)
22. Kitanaka S, Takeda A, Sato U, et al. A novel compound heterozygous mutation in the thyroglobulin gene resulting in congenital goitrous hypothyroidism with high serum triiodothyronine levels. J Hum Genet 2006; 51:379-382.
23. van de Graaf SA, Ris-Stalpers C, Pauws E, et al. Up to date with human thyroglobulin. J Endocrinol 2001; 170:307-321.
24. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004; 25:722-746. (Pubitemid 39362295)
25. Suzuki K, Lavaroni S, Mori A, et al. Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A 1998; 95:8251-8256. (Pubitemid 28326099)
26. Suzuki K, Kohn LD. Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J Endocrinol 2006; 189:247-255. (Pubitemid 43757783)
27. Leoni SG, Galante PA, Ricarte-Filho JCM, Kimura ET. Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3. Genomics 2008; 91:356-366.
28. Park YN, Arvan P. The acetylcholinesterase homology region is essential for normal conformational maturation and secretion of thyroglobulin. J Biol Chem 2004; 279:17085-17089. (Pubitemid 38560464)
29. Kim PS, Arvan P. Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum. J Cell Biol 1995; 128:29-38.
30. Kim PS, Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 1998; 19:173-202. (Pubitemid 29114290)
31. Lee J, Di Jeso B, Arvan P. The cholinesterase-like domain of thyroglobulin functions as an intramolecular chaperone. J Clin Invest 2008; 118:2950-2958. This study provides evidences to the understanding of the complex thyroglobulin structure and its secretory process.
32. Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003; 4:181-191.
33. Medeiros-Neto G, Kim PS, Yoo SE, et al. Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996; 98:2838-2844. (Pubitemid 26427413)
34. Kincaid MM, Cooper AA. Misfolded proteins traffic from the endoplasmic reticulum (ER) due to ER export signals. Mol Biol Cell 2007; 18:455-463. (Pubitemid 46213215)
35. Pardo V, Vono-Toniolo J, Rubio I G S, et al. The human p.A2215D TG gene mutation leads to deficient synthesis and secretion of the mutated protein and congenital hypothyroidism with a wide phenotype spectrum. J Clin Endocrinol Metab 2009 [Epub ahead of print]. Seventeen patients with thyroglobulin mutations are described in detail. Moreover functional studies show deficiency of the mutant thyroglobulin secretion.
36. Marino M, McCluskey RT. Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 2000; 279:C1295-C1306. (Pubitemid 30951954)
37. Botta R, Lisi S, Pinchera A, et al. Sortilin is a putative postendocytic receptor of thyroglobulin. Endocrinology 2009; 150:509-518.
38. Targovnik HM, Medeiros-Neto G, Varela V, et al. A nonsense mutation causes human hereditary congenital goiter with preferential production of a 171-nucleotide-deleted thyroglobulin ribonucleic acid messenger. J Clin Endocrinol Metab 1993; 77:210-215. (Pubitemid 23206805)
39. Ieiri T, Cochaux P, Targovnik HM, et al. A 30 splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 1991; 88:1901-1905.
40. Hishinuma A, Fukata S, Nishiyama S, et al. Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab 2006; 91:3100-3104. (Pubitemid 44271763)
41. Fugazzola L, Cerutti N, Mannavola D, et al. Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J Clin Endocrinol Metab 2003; 88:3264-3271. (Pubitemid 36877503)
42. Machiavelli GA, Caputo M, Rivolta CM, et al. Molecular analysis of congenital goitres with hypothyroidism caused by defective thyroglobulin synthesis. Identification of a novel c.7006C>T [p.R2317X] mutation and expression of minigenes containing nonsense mutations in exon 7. Clin Endocrinol (Oxf) 2009. [Epub ahead of print]
43. Hishinuma A, Takamatsu J, Ohyama Y, et al. Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin cause a defect in intracellular transport of thyroglobulin in patients with congenital goiter and the variant type of adenomatous goiter. J Clin Endocrinol Metab 1999; 84:1438-1444. (Pubitemid 30644412)
44. Hishinuma A, Kasai K, Masawa N, et al. Missense mutation (C1263R) in the thyroglobulin gene causes congenital goiter with mild hypothyroidism by impaired intracellular transport. Endocr J 1998; 45:315-327. (Pubitemid 128508703)
45. Targovnik HM, Rivolta CM, Mendive FM, et al. Congenital goiter with hypothyroidism caused by a 50 splice site mutation in the thyroglobulin gene. Thyroid 2001; 11:685-690. (Pubitemid 32701590)
46. Alzahrani AS, Baitei EY, Zou M, Shi Y. Metastatic follicular thyroid carcinoma arising from congenital goiter as a result of a novel splice donor site mutation in the thyroglobulin gene. J Clin Endocrinol Metab 2006; 91:740-746. (Pubitemid 43357732)
47. Gutnisky VJ, Moya CM, Rivolta CM, et al. Two distinct compound heterozygous constellations (R277X/IVS34-1G>C and R277X/R1511X) in the thyroglobulin (TG) gene in affected individuals of a Brazilian kindred with congenital goiter and defective TG synthesis. J Clin Endocrinol Metab 2004; 89:646-657.
48. Vono J, Lima N, Knobel M, Medeiros-Neto G. The effect of oral administration of iodine to patients with goiter and hypothyroidism due to defective synthesis of thyroglobulin. Thyroid 1996; 6:11-15. (Pubitemid 26086063)
49. Kim PS, Lee J, Jongsamak P, et al. Defective protein folding and intracellular retention of thyroglobulin-R19K mutant as a cause of human congenital goiter. Mol Endocrinol 2008; 22:477-484. This study shows that the amino-terminal domain of thyrogloblin has global effects on thyroglobulin transport and thyroid hormonogenesis. (Pubitemid 351185943)
50. Reynolds BC, Simpson JH, Macara L, et al. Goitrous congenital hypothyroidism in a twin pregnancy causing respiratory obstruction at birth: implications for management. Acta Paediatrica 2006; 95:1345-1348.
51. Caron P, Moya CM, Malet D, et al. Compound heterozygous mutations in the thyroglobulin gene (1143delC and 6725G->A [R2223H]) resulting in fetal goitrous hypothyroidism. J Clin Endocrinol Metab 2003; 88:3546-3553. (Pubitemid 37034493)
52. Mayor-Lynn KA, Rohrs HJ 3rd, Cruz AC, et al. Antenatal diagnosis and treatment of a dyshormonogenetic fetal goiter. J Ultrasound Med 2009; 28:67-71.
53. Francois A, Hindryckx A, Vandecruys H, et al. Fetal treatment for early dyshormonogenetic goiter. Prenat Diagn 2009; 29:543-545.
54. Rivolta CM, Moya CM, Gutnisky VJ, et al. A new case of congenital goiter with hypothyroidism caused by a homozygous p.R277X mutation in the exon 7 of the thyroglobulin gene: a mutational hot spot could explain the recurrence of this mutation. J Clin Endocrinol Metab 2005; 90:3766-3770.
55. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 78:151-155. (Pubitemid 18069872)
56. Hishinuma A, Fukata S, Kakudo K, et al. High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid 2005; 15:1079-1084. (Pubitemid 41475720)
57. Matakidou A, Hamel N, Popat S, et al. Risk of nonmedullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. Carcinogenesis 2004; 25:369-373. (Pubitemid 38344403)
58. Medeiros-Neto G, Gil-da-Costa MJ, Santos CLS, et al. Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene. J Clin Endocrinol Metab 1998; 83:4162-4166. (Pubitemid 28513611)
59. Camargo R, Limbert E, Gillam M, et al. Aggressive metastatic follicular thyroid carcinoma with anaplastic transformation arising from a long-standing goiter in a patient with Pendred's syndrome. Thyroid 2001; 11:981-988. (Pubitemid 33020188)
60. Morris HP, Dalton AJ, Green CD. Malignant thyroid tumors occurring in the mouse after prolonged hormonal imbalance during the ingestion of thiouracil. J Clin Endocrinol Metab 1951; 11:1281-1295.
61. Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999; 10:583-595.
62. Maier J, van Steeg H, van Oostrom C, et al. Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 2006; 147:3391-3397. (Pubitemid 43901130)
63. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009; 32:231-239. A very good review for thyroid autoimmunity including the association of thyroglobulin gene mutations with this pathology.